IONIS PHARMACEUTICALS INC
For the period ended Dec 31, 2023. Filed Feb 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 21, 2024
IONS$31.00-21.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net loss | $(366,286) | $(269,722) | $(28,597) |
| Unrealized gains (losses) on investments, net of tax | 24,484 | (24,395) | (11,486) |
| Currency translation adjustment | 351 | (417) | (111) |
| Comprehensive loss | $(341,451) | $(294,534) | $(40,194) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.